ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,225.33
-0.27%
Dow Jones
39,127.80
0.04%
Gold vs US Dollar
2,298.09
-0.97%
Brent Oil
84.46
0.33%
Bitcoin
60,990.59
-1.33%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Ocugen Inc (OCGN) Share Price

OCGN Ocugen Inc

1.25
0.07 (5.93%)
After Hours
Last Updated: 21:30:51
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Ocugen Inc NASDAQ:OCGN NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.07 5.93 1.25 1.25 1.27 1.3082 1.15 1.21 5,640,947 20:30:51   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 6.04M -63.08M -0.2451 -5.18 326.81M
 Type  Size  Price  Time  Units 
 9 9 1.25 20:45:02 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore OCGN News
21/06/202412:00GLOBEOcugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease
20/06/202411:30GLOBEOcugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400—First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication
18/06/202421:29EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/06/202421:31EDGAR2Form 8-K - Current report
31/05/202413:36GLOBEData and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy
29/05/202412:15GLOBEOcugen to Present at BIO International Convention 2024
28/05/202421:05EDGAR2Form DEF 14A - Other definitive proxy statements
Period
Draw mode
Data Downloads for OCGN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Ocugen Inc Articles